Original Research
Published on 11 Nov 2025
TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study
in Cancer Immunity and Immunotherapy
- 449 views
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Nov 2025
in Public Health Policy
Original Research
Published on 11 Nov 2025
in Nutrition and Sustainable Diets
Review
Published on 11 Nov 2025
in Adaptive immunity in infection
Original Research
Published on 11 Nov 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Nov 2025
in Tissue Engineering and Regenerative Medicine
Original Research
Published on 11 Nov 2025
in Comparative Immunology
Original Research
Published on 11 Nov 2025
in Exercise Physiology
Original Research
Published on 11 Nov 2025
in Medical Physics and Imaging
Original Research
Published on 11 Nov 2025
in Vaccines and Molecular Therapeutics
Original Research
Published on 11 Nov 2025
in Soil Processes
Review
Published on 11 Nov 2025
in Occupational and Environmental Epidemiology
Perspective
Published on 11 Nov 2025
in Radiation Oncology
Original Research
Published on 11 Nov 2025
in Autism
Opinion
Published on 11 Nov 2025
in Healthcare Professions Education